ReNeuron Successfully Automates Its Stem Cell Manufacturing Process on The Automation Partnership's CompacT SelecT System

CAMBRIDGE, England--(BUSINESS WIRE)--ReNeuron, a leading UK-based stem cell company, today announced the publication of a paper in the journal Biotechnology Letters demonstrating successful automation of the manufacturing of its ReN001 neural stem cell line for stroke in TAP’s CompacT SelecT™ automated cell culture system.

Back to news